Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 7Phase 3 4Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 9Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4HER2-positive Breast Cancer 4Prostatic Neoplasms 3Motor Activity 3Melanoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Depression 3Colorectal Neoplasms 3Sarcoma 2Peripheral Nervous System Diseases 2Ovarian Neoplasms 2Fatigue 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Carcinoma In Situ 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Incontinence 1To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients 1Smoking 1Sleepiness 1Seroma 1Recurrence 1Radiodermatitis 1

Interventions

Low-Level Light Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Radiation Injuries × Breast × Clear all
NCT04059809 2021-08-13

Photobiomodulation for Breast Cancer Radiodermatitis

AC Camargo Cancer Center

Phase 2/3 Completed
48 enrolled
Breast

Breast Neoplasms, Radiation Injuries, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡